| |
[5. Nov 2021|09:33] |
Un tagad par "zinātni", kurai mums esot jātic. Īsumā. Tiek taisītas faizer pārbaudes, dati tiek viltoti, ziņotājs atlaists, uzraugošā institūcija sadarbojas ar viltotājiem, lai atlaistu ziņotāju un neko nedara situācijas uzlabošanai, faizers nolīgst šo pašu kompāniju lai pārbaudītu "vakcīnas" bērniem, grūtniecēm un papildusdevām pieaugušajiem.
Kompānija Ventavia Research Group kura uzrauga faizer "vakcīnas" pārbaudes, vilto pārbaužu datus. Un atlaida cilvēku, kurš par to ziņoja cilvēkiem.
Company That Managed Pfizer Vaccine Trial Sites ‘Falsified Data’: Whistleblower
https://science.thewire.in/the-sciences/company-that-managed-pfizer-vaccine-trial-sites-falsified-data-whistleblower/
"...and was slow to follow up on adverse events. ... Despite Jackson repeatedly notifying Ventavia of the problems, the company reportedly took no corrective action. This prompted Jackson(regional director) to send a complaint by email to the US Food and Drug Administration (FDA) ... In a further surprise, the FDA did not follow up on Jackson’s complaint either. ... the revelations suggest the data could have been skewed by samples not being collected from participants who had had COVID-like symptoms. ... she said she witnessed “poor laboratory management, patient safety concerns, and data integrity issues” ... Jackson also recorded a meeting with two Ventavia directors in late September 2020 – in which one of them admitted that the company “wasn’t able to quantify the types and number of errors they were finding when examining the trial paperwork for quality control”. ... On September 25, 2020 – which was the following morning – Jackson said she called the FDA and warned the agency about unsound practices in Pfizer’s clinical trial at Ventavia, and also articulated her concerns in an emailed complaint. Ventavia fired her that afternoon. ...
1. Participants placed in a hallway after injection and not being monitored by clinical staff
2. Lack of timely follow-up of patients who experienced adverse events
3. Protocol deviations not being reported
4. Vaccines not being stored at proper temperatures
5. Mislabelled laboratory specimens, and
6. Targeting Ventavia staff for reporting these types of problems
Pfizer has since hired Ventavia as a research subcontractor for four other vaccine clinical trials. These include trials on COVID-19 vaccines for children and young adults, pregnant women, and a booster dose.
|
|
|
